Skip to main content

Table 1 Correlation between EIF4G2 expression and clinicopathological characteristics

From: MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway

Variables

EIF4G2 expression

χ2

p-value

high

low

Age (year)

  

4.066

0.044

  ≤ 50

24

15

  

 >50

20

30

  

Sex

  

0.001

0.970

 Female

5

5

  

 Male

39

40

  

Grade

  

3.236

0.072

 1/2

25

17

  

 3

19

28

  

T stage

  

6.612

0.010

 T1

34

23

  

 T2/T3

10

22

  

TNM stage

  

6.612

0.010

 Ι

34

23

  

 II/III

10

22

  

PDL1

  

4.443

0.035

 Negative

30

20

  

 Positive

12

21

  

Recurrence

  

4.048

0.044

 No

25

16

  

 Yes

19

29

  
  1. Note: Bold p values display statistical significance, p < 0.05